Anixa Biosciences

ANIX NASDAQ
4.111
-0.089
-2.12%
交易中 10:56 05/23 EDT
开盘
4.160
昨收
4.200
最高
4.160
最低
4.111
成交量
2,402
成交均量(3M)
5.12万
52周最高
6.86
52周最低
2.960
换手率
0.01%
市值
8,069.32万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供Anixa Biosciences ANIX股票价格,Anixa Biosciences股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Anixa Biosciences, Inc., formerly ITUS Corporation, is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. Instead of seeking to alter or boost the body's immune system and its ability to destroy cancer cells, the Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients, and in distinguishing the blood of healthy patients from the blood of cancer patients.
展开 >

最近浏览

名称
价格
涨跌幅